Document
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________
FORM 10-Q
_________________________________
(Mark One)
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2018
OR
o 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
 
to
     
Commission File Number: 001-11593
______________________________________________ 
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
______________________________________________
OHIO
 
31-1414921
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
14111 SCOTTSLAWN ROAD,
MARYSVILLE, OHIO
 
43041
(Address of principal executive offices)
 
(Zip Code)
(937) 644-0011
(Registrant’s telephone number, including area code)
______________________________________________ 
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  o 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  o 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
ý
  
Accelerated filer
 
o 
Non-accelerated filer
 
o  (Do not check if a smaller reporting company)
  
Smaller reporting company
 
o 
Emerging growth company
 
o 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o     No  ý
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
 
Class
    
Outstanding at May 4, 2018
 
 
Common Shares, $0.01 stated value, no par value
    
55,365,798 Common Shares
 

1
Table of Contents


THE SCOTTS MIRACLE-GRO COMPANY
INDEX

 
 
 
 
 
PAGE NO.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

2
Table of Contents

PART I—FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidated Statements of Operations
(In millions, except per common share data)
(Unaudited)
 
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
Net sales
$
1,013.3

 
$
1,084.6

 
$
1,234.9

 
$
1,292.0

Cost of sales
604.1

 
620.3

 
791.7

 
790.9

Gross profit
409.2

 
464.3

 
443.2

 
501.1

Operating expenses:
 
 
 
 
 
 
 
Selling, general and administrative
166.0

 
178.8

 
274.2

 
282.9

Impairment, restructuring and other
10.2

 
1.0

 
10.0

 
0.8

Other (income) expense, net
0.7

 
(0.8
)
 
(1.4
)
 
(6.1
)
Income from operations
232.3

 
285.3

 
160.4

 
223.5

Equity in (income) loss of unconsolidated affiliates
(1.5
)
 
24.1

 
(2.1
)
 
37.3

Interest expense
22.6

 
21.5

 
40.4

 
36.8

Other non-operating expense, net
9.2

 
—

 
6.7

 
—

Income from continuing operations before income taxes
202.0

 
239.7

 
115.4

 
149.4

Income tax expense (benefit) from continuing operations
49.3

 
85.6

 
(17.3
)
 
53.4

Income from continuing operations
152.7

 
154.1

 
132.7

 
96.0

Income (loss) from discontinued operations, net of tax
(3.7
)
 
11.1

 
(4.9
)
 
4.3

Net income
$
149.0

 
$
165.2

 
$
127.8

 
$
100.3

Net income attributable to noncontrolling interest
(0.1
)
 
(0.1
)
 
(0.1
)
 
(0.5
)
Net income attributable to controlling interest
$
148.9

 
$
165.1

 
$
127.7

 
$
99.8

 
 
 
 
 
 
 
 
Basic income (loss) per common share:
 
 
 
 
 
 
 
Income from continuing operations
$
2.70

 
$
2.58

 
$
2.33

 
$
1.59

Income (loss) from discontinued operations
(0.06
)
 
0.18

 
(0.09
)
 
0.08

Basic income (loss) per common share
$
2.64

 
$
2.76

 
$
2.24

 
$
1.67

Weighted-average common shares outstanding during the period
56.5

 
59.8

 
57.0

 
60.0

 
 
 
 
 
 
 
 
Diluted income (loss) per common share:
 
 
 
 
 
 
 
Income from continuing operations
$
2.66

 
$
2.54

 
$
2.29

 
$
1.57

Income (loss) from discontinued operations
(0.07
)
 
0.19

 
(0.09
)
 
0.07

Diluted income (loss) per common share
$
2.59

 
$
2.73

 
$
2.20

 
$
1.64

Weighted-average common shares outstanding during the period plus dilutive potential common shares
57.4

 
60.6

 
58.0

 
60.9

 
 
 
 
 
 
 
 
Dividends declared per common share
$
0.530

 
$
0.500

 
$
1.060

 
$
1.000

See Notes to Condensed Consolidated Financial Statements.

3
Table of Contents

THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidated Statements of Comprehensive Income (Loss)
(In millions)
(Unaudited)
 

 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
Net income
$
149.0

 
$
165.2

 
$
127.8

 
$
100.3

Other comprehensive income (loss):
 
 
 
 
 
 
 
Net foreign currency translation adjustment
15.8

 
1.8

 
15.7

 
(2.2
)
Net unrealized gain (loss) on derivative instruments, net of tax of $0.8, $0.0, $1.1 and $1.9, respectively
2.0

 
—

 
2.8

 
3.0

Reclassification of net unrealized (gain) loss on derivatives to net income, net of tax of $(0.4), $0.7, $(0.5) and $0.9, respectively
(1.1
)
 
1.1

 
(1.2
)
 
1.5

Reclassification of net pension and other post-retirement benefits loss to net income, net of tax of $0.1, $0.3, $0.2 and $0.6, respectively
0.3

 
0.5

 
0.6

 
0.9

Total other comprehensive income
17.0

 
3.4

 
17.9

 
3.2

Comprehensive income
$
166.0

 
$
168.6

 
$
145.7

 
$
103.5

See Notes to Condensed Consolidated Financial Statements.


4
Table of Contents

THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidated Statements of Cash Flows
(In millions) (Unaudited)
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
OPERATING ACTIVITIES
 
 
 
Net income
$
127.8

 
$
100.3

Adjustments to reconcile net income to net cash used in operating activities:
 
 
 
Share-based compensation expense
15.7

 
15.1

Depreciation
25.5

 
27.6

Amortization
14.1

 
12.3

Deferred taxes
(45.9
)
 
—

(Gain) loss on long-lived assets
(0.2
)
 
0.8

Loss on sale / contribution of business
3.5

 
(0.3
)
Recognition of accumulated foreign currency translation loss
11.7

 
—

Equity in (income) loss and distributions from unconsolidated affiliates
(2.1
)
 
39.5

Changes in assets and liabilities, net of acquired businesses:
 
 
 
Accounts receivable
(643.0
)
 
(749.9
)
Inventories
(184.1
)
 
(207.9
)
Prepaid and other assets
(9.1
)
 
(29.0
)
Accounts payable
113.9

 
167.1

Other current liabilities
97.3

 
148.1

Restructuring
5.2

 
(14.6
)
Other non-current items
(12.9
)
 
1.8

Other, net
(0.2
)
 
0.1

Net cash used in operating activities
(482.8
)
 
(489.0
)
 
 
 
 
INVESTING ACTIVITIES
 
 
 
Proceeds from sale of long-lived assets
0.2

 
4.8

Post-closing working capital payment related to sale of International Business
(35.3
)
 
—

Investments in property, plant and equipment
(33.1
)
 
(32.8
)
Investments in loans receivable
(7.7
)
 
—

Net investments in unconsolidated affiliates
—

 
(0.2
)
Investments in acquired businesses, net of cash acquired
(144.2
)
 
(77.9
)
Net cash used in investing activities
(220.1
)
 
(106.1
)
 
 
 
 
FINANCING ACTIVITIES
 
 
 
Borrowings under revolving and bank lines of credit and term loans
1,172.6

 
944.6

Repayments under revolving and bank lines of credit and term loans
(243.4
)
 
(395.0
)
Proceeds from issuance of 5.250% Senior Notes
—

 
250.0

Financing and issuance fees
—

 
(3.9
)
Dividends paid
(60.3
)
 
(59.9
)
Distribution paid by AeroGrow to noncontrolling interest
—

 
(8.1
)
Purchase of Common Shares
(256.8
)
 
(99.2
)
Payments on seller notes
(3.0
)
 
(13.2
)
Excess tax benefits from share-based payment arrangements
—

 
4.0

Cash received from the exercise of stock options
3.8

 
1.7

Net cash provided by financing activities
612.9

 
621.0

Effect of exchange rate changes on cash
2.5

 
(1.7
)
Net increase (decrease) in cash and cash equivalents
(87.5
)
 
24.2

Cash and cash equivalents at beginning of period excluding cash classified within assets held for sale
120.5

 
28.6

Cash and cash equivalents at beginning of period classified within assets held for sale
—

 
21.5

Cash and cash equivalents at beginning of period
120.5

 
50.1

Cash and cash equivalents at end of period
$
33.0

 
$
74.3

See Notes to Condensed Consolidated Financial Statements.

5
Table of Contents

THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidated Balance Sheets
(In millions, except stated value per share)
(Unaudited)
 
 
MARCH 31,
2018
 
APRIL 1,
2017
 
SEPTEMBER 30,
2017
ASSETS
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
33.0

 
$
55.4

 
$
120.5

Accounts receivable, less allowances of $6.9, $6.9 and $3.1, respectively
598.0

 
978.3

 
197.7

Accounts receivable pledged
333.3

 
—

 
88.9

Inventories
596.9

 
596.5

 
407.5

Assets held for sale
—

 
331.5

 
—

Prepaid and other current assets
78.1

 
85.7

 
67.1

Total current assets
1,639.3

 
2,047.4

 
881.7

Investment in unconsolidated affiliates
33.2

 
59.9

 
31.1

Property, plant and equipment, net of accumulated depreciation of $614.2, $570.9 and $591.1, respectively
463.6

 
437.1

 
467.7

Goodwill
466.8

 
400.6

 
441.6

Intangible assets, net
777.6

 
726.8

 
748.9

Other assets
195.0

 
120.2

 
176.0

Total assets
$
3,575.5

 
$
3,792.0

 
$
2,747.0

 
 
 
 
 
 
LIABILITIES AND EQUITY
Current liabilities:
 
 
 
 
 
Current portion of debt
$
335.8

 
$
32.1

 
$
143.1

Accounts payable
253.5

 
270.8

 
153.1

Liabilities held for sale
—

 
154.7

 
—

Other current liabilities
316.8

 
318.1

 
248.3

Total current liabilities
906.1

 
775.7

 
544.5

Long-term debt
1,937.7

 
2,042.9

 
1,258.0

Distributions in excess of investment in unconsolidated affiliate
21.9

 
—

 
21.9

Other liabilities
213.9

 
282.0

 
260.9

Total liabilities
3,079.6

 
3,100.6

 
2,085.3

Commitments and contingencies (Note 12)

 

 

Equity:
 
 
 
 
 
Common shares and capital in excess of $.01 stated value per share; 55.6, 59.6 and 58.1 shares issued and outstanding, respectively
409.0

 
399.8

 
407.6

Retained earnings
1,044.5

 
921.0

 
978.2

Treasury shares, at cost; 12.5, 8.5 and 10.0 shares, respectively
(911.4
)
 
(528.2
)
 
(667.8
)
Accumulated other comprehensive loss
(51.3
)
 
(113.7
)
 
(69.2
)
Total equity—controlling interest
490.8

 
678.9

 
648.8

Noncontrolling interest
5.1

 
12.5

 
12.9

Total equity
495.9

 
691.4

 
661.7

Total liabilities and equity
$
3,575.5

 
$
3,792.0

 
$
2,747.0

See Notes to Condensed Consolidated Financial Statements.

6
Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations
The Scotts Miracle-Gro Company (“Scotts Miracle-Gro” or “Parent”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of branded products for lawn and garden care and indoor and hydroponic gardening. The Company’s primary customers include home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, food and drug stores, indoor gardening and hydroponic product distributors and retailers. The Company’s products are sold primarily in North America, Europe and Asia.
Prior to August 31, 2017, the Company operated consumer lawn and garden businesses located in Australia, Austria, Belgium, Luxembourg, Czech Republic, France, Germany, Poland and the United Kingdom (the “International Business”). On April 29, 2017, the Company received a binding and irrevocable conditional offer (the “Offer”) from Exponent Private Equity LLP (“Exponent”) to purchase the International Business. On July 5, 2017, the Company accepted the Offer and entered into the Share and Business Sale Agreement (the “Agreement”) contemplated by the Offer. Pursuant to the Agreement, Scotts-Sierra Investments LLC, an indirect wholly-owned subsidiary of the Company (“Sierra”) and certain of its direct and indirect subsidiaries, entered into separate stock or asset sale transactions with respect to the the International Business. As a result, effective in its fourth quarter of fiscal 2017, the Company classified its results of operations for all periods presented to reflect the International Business as a discontinued operation and classified the assets and liabilities of the International Business as held for sale. See “NOTE 2. DISCONTINUED OPERATIONS” for further discussion. Refer to “NOTE 15. SEGMENT INFORMATION” for discussion of the Company’s new reportable segments effective in the fourth quarter of fiscal 2017.
Due to the nature of the consumer lawn and garden business, the majority of the Company’s sales to customers occur in the Company’s second and third fiscal quarters. On a combined basis, net sales for the second and third quarters of the last three fiscal years represented in excess of 75% of the Company’s annual net sales.
Organization and Basis of Presentation
The Company’s unaudited condensed consolidated financial statements for the three and six months ended March 31, 2018 and April 1, 2017 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. AeroGrow International, Inc. (“AeroGrow”), in which the Company has a controlling interest, is consolidated, with the equity owned by other shareholders shown as noncontrolling interest in the Condensed Consolidated Balance Sheets, and the other shareholders’ portion of net earnings and other comprehensive income shown as net income (loss) or comprehensive (income) loss attributable to noncontrolling interest in the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income (Loss), respectively. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this report should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2017 (the “2017 Annual Report”), which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.
The Company’s Condensed Consolidated Balance Sheet at September 30, 2017 has been derived from the Company’s audited Consolidated Balance Sheet at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

7
Table of Contents

Loans Receivable
Loans receivable are carried at outstanding principal amount, and are recognized in the “Other assets” line in the Condensed Consolidated Balance Sheets. Loans receivable are impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement. If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the asset exceeds the present value of expected future cash flows and recorded in operating expenses in the Condensed Consolidated Statements of Operations.
Interest income is recorded on an accrual basis. For the three and six months ended March 31, 2018, the Company has classified interest income on loans receivable of $2.5 million and $5.0 million, respectively, in the “Other non-operating expense, net” line in the Condensed Consolidated Statements of Operations. For the three and six months ended April 1, 2017, interest income on loans receivable of $2.1 million and $4.8 million, respectively, is classified in the “Other (income) expense, net” line in the Condensed Consolidated Statements of Operations.
Long-Lived Assets
The Company had non-cash investing activities of $3.3 million and $2.3 million during the six months ended March 31, 2018 and April 1, 2017, respectively, representing unpaid liabilities incurred during each period to acquire property, plant and equipment.
Statements of Cash Flows
Supplemental cash flow information was as follows:
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
(In millions)
Interest paid
$
(35.7
)
 
$
(26.5
)
Income taxes paid
(14.5
)
 
(3.2
)
Property and equipment acquired under capital leases
—

 
(0.6
)
During the six months ended March 31, 2018, the Company paid contingent consideration of $3.0 million related to the fiscal 2016 acquisition of Gavita Holdings B.V., and its subsidiaries (collectively, “Gavita”). During the six months ended April 1, 2017, the Company paid contingent consideration of $6.7 million and $6.5 million, respectively, related to the fiscal 2014 acquisition of Fafard & Brothers Ltd. (“Fafard”) and the fiscal 2016 acquisition of a Canadian growing media operation.
The Company uses the “cumulative earnings” approach for determining cash flow presentation of distributions from unconsolidated affiliates. Distributions received are included in the Condensed Consolidated Statements of Cash Flows as operating activities, unless the cumulative distributions exceed the portion of the cumulative equity in the net earnings of the unconsolidated affiliate, in which case the excess distributions are deemed to be returns of the investment and are classified as investing activities in the Condensed Consolidated Statements of Cash Flows.
RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS
Income Taxes
On December 22, 2017, H.R.1 (the “Act,” formerly known as the “Tax Cuts and Jobs Act”) was signed into law and provides for significant changes to the U.S. Internal Revenue Code of 1986, as amended (the “Code”). Among other items, the Act implements a territorial tax system, imposes a one-time transition tax on deemed repatriated earnings of foreign subsidiaries, and permanently reduces the federal corporate tax rate to 21% effective January 1, 2018.
Additionally, the SEC released Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance on accounting for the Act’s impact under Accounting Standards Codification (“ASC”) Topic 740, Income Taxes (“ASC 740”). The guidance in SAB 118 addresses certain fact patterns where the accounting for changes in tax laws or tax rates under ASC 740 is incomplete upon issuance of an entity's financial statements for the reporting period in which the Act is enacted. Under the staff guidance in SAB 118, in the financial reporting period in which the Act is enacted, the income tax effects of the Act (i.e., only for those tax effects in which the accounting under ASC 740 is incomplete) would be reported as a provisional amount based on a reasonable estimate (to the extent a reasonable estimate can be determined), which would be subject to adjustment during a “measurement period” until the accounting under ASC 740 is complete. The measurement period is limited to no more than one year beyond the enactment date under the staff's guidance. SAB 118 also describes supplemental disclosures that should accompany the provisional amounts,

8
Table of Contents

including the reasons for the incomplete accounting, the additional information or analysis that is needed, and other information relevant to why the registrant was not able to complete the accounting required under ASC 740 in a timely manner.
For discussion of the impacts of the Act that are material to the Company and required disclosures related to the Act pursuant to the guidance provided under SAB 118, refer to “NOTE 11. INCOME TAXES.”
Share-Based Compensation
In March 2016, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update that simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company adopted this guidance effective October 1, 2017. The impact resulting from the adoption of this amended guidance is summarized below.
The amended accounting guidance requires all excess tax benefits and tax deficiencies to be recognized as income tax benefit or expense on a prospective basis in the period of adoption. The adoption of this provision of the amended accounting guidance resulted in the recognition of excess tax benefits of $1.5 million and $1.9 million in the “Income tax expense (benefit) from continuing operations” line in the Condensed Consolidated Statement of Operations for the three and six months ended March 31, 2018, respectively. As the Company adopted the guidance on a prospective basis, prior year activity has not been adjusted to conform with the current presentation and excess tax benefits of $3.2 million and $4.0 million have been recognized in the “Capital in excess of stated value” line within “Total equity—controlling interest” in the Condensed Consolidated Balance Sheets for the three and six months ended April 1, 2017, respectively.
The amended accounting guidance requires excess tax benefits to be classified as an operating activity in the statement of cash flows. Previously, excess tax benefits were presented as a cash inflow from financing activities and cash outflow from operating activities. The Company has elected to present these changes on a prospective basis and therefore the six months ended April 1, 2017 has not been adjusted to conform with the current presentation.
The amended accounting guidance requires cash paid to a tax authority when shares are withheld to satisfy statutory income tax withholding obligations to be classified as a financing activity in the statement of cash flows. The Company’s retrospective adoption of this provision of the amended accounting guidance resulted in the classification of payments of $2.9 million and $8.8 million as cash outflows from financing activities for the six months ended March 31, 2018 and April 1, 2017, respectively.
The Company has elected to continue to estimate the number of awards expected to vest, as permitted by the amended accounting guidance, rather than electing to account for forfeitures as they occur.
Derivatives and Hedging
In August 2017, the FASB issued an accounting standard update that modifies hedge accounting by making more hedge strategies eligible for hedge accounting, amending presentation and disclosure requirements, and changing how companies assess effectiveness. The intent is to simplify application of hedge accounting and increase transparency of information about an entity’s risk management activities. The Company early adopted this guidance effective October 1, 2017. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
Inventory
In July 2015, the FASB issued an accounting standard update that requires inventory to be measured “at the lower of cost and net realizable value,” thereby simplifying the current guidance that requires inventory to be measured at the lower of cost or market (market in this context is defined as one of three different measures, one of which is net realizable value). The Company adopted this guidance on a prospective basis effective October 1, 2017. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
Income Taxes
In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred income tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The Company adopted this guidance on a retrospective basis during the fourth quarter of fiscal 2017. As a result, deferred tax assets totaling $43.1 million have been presented net within other liabilities in the Condensed Consolidated Balance Sheet as of April 1, 2017. This amount was previously reported within prepaid and other current assets.

9
Table of Contents

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
Revenue Recognition from Contracts with Customers
In May 2014, the FASB issued amended accounting guidance that replaces most existing revenue recognition guidance under GAAP. This guidance requires companies to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in amounts that reflect the consideration to which a company expects to be entitled in exchange for those goods or services. The standard involves a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when the entity satisfies the performance obligations. The new standard also will result in enhanced disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Subsequently, additional guidance was issued on several areas including guidance intended to improve the operability and understandability of the implementation of principal versus agent considerations and clarifications on the identification of performance obligations and implementation of guidance related to licensing.
The Company has made progress on its evaluation of the amended guidance, including identification of revenue streams and customer contract reviews. The Company is applying the five-step model to those contracts and revenue streams to evaluate the quantitative and qualitative impacts the new standard will have on its business and reported revenues. The provisions are effective for the Company in the first quarter of fiscal 2019 and the Company expects to adopt under the modified retrospective approach, which recognizes the cumulative effect of adoption as an adjustment to retained earnings at the date of initial application. The Company’s revenue is primarily product sales, which are recognized at a point in time when title transfers to customers and the Company has no further obligation to provide services related to such products. Although the Company is continuing to assess the impact of the amended guidance, it generally anticipates that its timing of recognition of revenue will be substantially unchanged under the amended guidance.
Leases
In February 2016, the FASB issued an accounting standard update which significantly changes the accounting for leases. This guidance requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2019 and require a modified retrospective transition approach for leases that exist as of or are entered into after the beginning of the earliest comparative period presented in the financial statements. The Company is currently evaluating the impact of this standard on its consolidated results of operations, financial position and cash flows. The Company has made progress on its evaluation of the amended guidance, including identification of the population of leases affected, determining the information required to calculate the lease liability and right-of-use asset and evaluating models to assist in future reporting.
Cash Flow Presentation
In August 2016, the FASB issued an accounting standard update that amends the guidance on the classification of certain cash receipts and payments in the statement of cash flows. The provisions are effective retrospectively for the Company’s financial statements no later than the fiscal year beginning October 1, 2018, and are not expected to have a significant impact on the Company’s consolidated cash flows.
Business Combinations
In January 2017, the FASB issued an accounting standard update that clarifies the definition of a business to provide additional guidance to assist in evaluating whether transactions should be accounted for as an acquisition (or disposal) of either an asset or business. The provisions are effective prospectively for the Company’s financial statements no later than the fiscal year beginning October 1, 2018, and are not expected to have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
Goodwill
In January 2017, the FASB issued an accounting standard update which removes the requirement to compare the implied fair value of goodwill with its carrying amount as part of step 2 of the goodwill impairment test. Goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of the goodwill. The provisions are effective prospectively for the Company’s financial statements no later than the fiscal year beginning October 1, 2020, and are not expected to have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.

10
Table of Contents

Employee Benefit Plans
In March 2017, the FASB issued an accounting standard update which requires entities to (1) disaggregate the current-service-cost component from the other components of net benefit cost (the “other components”) and present it with other current compensation costs for related employees in the income statement, (2) present the other components elsewhere in the income statement and outside of income from operations if that subtotal is presented and (3) limit the amount of costs eligible for capitalization (e.g., as part of inventory or property, plant, and equipment) to only the service-cost component of net benefit cost. The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2018, and are required to be applied retrospectively for the presentation of cost components in the income statement and prospectively for the capitalization of cost components. The provisions are not expected to have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
NOTE 2. DISCONTINUED OPERATIONS
International Business
On August 31, 2017, the Company completed the sale of the International Business for cash proceeds of $150.6 million at closing, which is net of seller financing provided by the Company in the form of a $29.7 million loan for seven years bearing interest at 5% for the first three years, with annual 2.5% increases thereafter. The transaction also included contingent consideration, a non-cash investing activity, with a maximum payout of $23.8 million and an initial fair value of $18.2 million, the payment of which will depend on the achievement of certain performance criteria by the International Business following the closing of the transaction through fiscal 2020. The seller financing loan and the contingent consideration receivable are recorded in the “Other assets” line in the Condensed Consolidated Balance Sheets. The cash proceeds from the sale were subject to post-closing adjustments and the Company originally accrued $27.8 million at September 30, 2017 in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets related to the expected working capital adjustment obligation in respect of the actual closing date financial position of the International Business. The Company recorded a pre-tax gain on the sale of the International Business of $32.7 million, partially offset by the provision for income taxes of $12.0 million, during fiscal 2017. The fiscal 2017 pre-tax gain included a write-off of accumulated foreign currency translation loss adjustments of $18.5 million. During the three months ended March 31, 2018, the Company recorded a reduction to the gain of $3.7 million related to the resolution of the post-closing working capital adjustment obligation.
In connection with the transaction, the Company entered into certain ancillary agreements including a transition services agreement and a material supply agreement, which are not material, as well as a licensing agreement for the use of certain of the Company’s brand names with an initial fair value of $14.1 million.
During the three and six months ended March 31, 2018, the Company recognized $0.2 million and $1.6 million, respectively, as compared to $2.3 million and $3.9 million for the three and six months ended April 1, 2017, respectively, in transaction related costs associated with the sale of the International Business.

Scotts LawnService® 
On April 13, 2016, pursuant to the terms of the Contribution and Distribution Agreement (the “Contribution Agreement”) between the Company and TruGreen Holding Corporation (“TruGreen Holdings”), the Company completed the contribution of the Scotts LawnService® business (the “SLS Business”) to a newly formed subsidiary of TruGreen Holdings (the “TruGreen Joint Venture”) in exchange for a minority equity interest of approximately 30% in the TruGreen Joint Venture. As a result, effective in its second quarter of fiscal 2016, the Company classified its results of operations for all periods presented to reflect the SLS Business as a discontinued operation and classified the assets and liabilities of the SLS Business as held for sale.
During the three and six months ended April 1, 2017, the Company recognized $0.1 million and $0.7 million, respectively, in transaction related costs associated with the divestiture of the SLS Business. In addition, during the six months ended April 1, 2017, the Company recorded a reduction to the gain on the contribution of the SLS Business of $0.3 million related to a post-closing working capital adjustment.

11
Table of Contents

The following table summarizes the results of the International Business and SLS Business within discontinued operations for each of the periods presented:

THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
 
(In millions)
Net sales
$
—

 
$
118.9

 
$
—

 
$
158.2

Operating and exit costs
1.6

 
99.8

 
1.6

 
146.7

Impairment, restructuring and other
0.2

 
2.4

 
1.6

 
4.6

Other expense, net
—

 
0.2

 
—

 
0.1

Loss on sale / contribution of business
3.7

 
—

 
3.5

 
0.3

Interest expense
—

 
—

 
—

 
0.4

Income (loss) from discontinued operations before income taxes
(5.5
)
 
16.5

 
(6.7
)
 
6.1

Income tax expense (benefit) from discontinued operations
(1.8
)
 
5.4

 
(1.8
)
 
1.8

Income (loss) from discontinued operations, net of tax
$
(3.7
)
 
$
11.1

 
$
(4.9
)
 
$
4.3

The following table summarizes the major classes of assets and liabilities held for sale:
 
APRIL 1,
2017
 
(In millions)
Cash and cash equivalents
$
18.9

Accounts receivable, net
143.0

Inventories
62.0

Prepaid and other current assets
8.4

Property, plant and equipment, net
23.8

Goodwill and intangible assets, net
60.2

Other assets
15.2

Assets held for sale
$
331.5

 
 
Accounts payable
$
51.8

Other current liabilities
71.9

Long-term debt
12.2

Other liabilities
18.8

Liabilities held for sale
$
154.7

The Condensed Consolidated Statements of Cash Flows do not present the cash flows from discontinued operations separately from cash flows from continuing operations. Cash used in operating activities related to discontinued operations totaled zero and $65.9 million for the six months ended March 31, 2018 and April 1, 2017, respectively. Cash used in investing activities related to discontinued operations totaled $35.3 million and $3.1 million for the six months ended March 31, 2018 and April 1, 2017, respectively.
NOTE 3. ACQUISITIONS AND INVESTMENTS
Fiscal 2018
On May 26, 2016, the Company’s Hawthorne segment acquired majority control and a 75% economic interest in Gavita. Gavita’s former ownership group initially retained a 25% noncontrolling interest in Gavita consisting of ownership of 5% of the outstanding shares of Gavita and a loan with interest payable based on distributions by Gavita. The loan was recorded at fair value in the “Long-term debt” line in the Condensed Consolidated Balance Sheets. On October 2, 2017, the Company’s Hawthorne segment acquired the remaining 25% noncontrolling interest in Gavita, including Agrolux, for $69.2 million, plus payment of contingent consideration of $3.0 million. The carrying value of the 25% noncontrolling interest consisted of long-term debt of $55.6 million and noncontrolling interest of $7.9 million. The difference between purchase price and carrying value was recognized

12
Table of Contents

in the “Capital in excess of stated value” line within “Total equity—controlling interest” in the Condensed Consolidated Balance Sheets.
On October 11, 2017, the Company’s Hawthorne segment completed the acquisition of substantially all of the U.S. and Canadian assets of Can-Filters Group Inc. (“Can-Filters”) for $74.1 million. Based in British Columbia, Can-Filters is a leading wholesaler of ventilation products for indoor and hydroponic gardening and industrial markets worldwide. The preliminary valuation of the acquired assets included (i) $2.1 million of cash, prepaid and other current assets, (ii) $7.7 million of inventory and accounts receivable, (iii) $4.4 million of fixed assets, (iv) $0.7 million of accounts payable and other current liabilities, (v) $39.7 million of finite-lived identifiable intangible assets, and (vi) $20.9 million of tax-deductible goodwill. Identifiable intangible assets included tradenames and customer relationships with useful lives of 25 years. The estimated fair value of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Net sales for Can-Filters included within the Hawthorne segment for the three and six months ended March 31, 2018 were $3.4 million and $7.9 million, respectively.
Fiscal 2017
On August 11, 2017, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of the exclusive manufacturer and formulator of branded Botanicare® products for $32.0 million. The valuation of the acquired assets included (i) $0.3 million of inventory, (ii) $5.0 million of finite-lived identifiable intangible assets, and (iii) $26.7 million of tax-deductible goodwill. Identifiable intangible assets included manufacturing know-how and non-compete agreements with useful lives ranging between 5 and 10 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.
On May 26, 2017, the Company’s majority-owned subsidiary Gavita completed the acquisition of Agrolux Holding B.V., and its subsidiaries (collectively, “Agrolux”), for $21.8 million. Based in the Netherlands, Agrolux is a worldwide supplier of horticultural lighting. The purchase price included contingent consideration, a non-cash investing activity, with a maximum payout and estimated fair value of $5.2 million, which was paid subsequent to March 31, 2018. The valuation of the acquired assets included (i) $8.0 million of cash, prepaid and other current assets, (ii) $10.1 million of inventory and accounts receivable, (iii) $0.5 million of fixed assets, (iv) $8.6 million of accounts payable and other current liabilities, (v) $6.7 million of short term debt, (vi) $16.1 million of finite-lived identifiable intangible assets, (vii) $6.4 million of non-deductible goodwill, and (viii) $4.0 million of deferred tax liabilities. Identifiable intangible assets included tradenames and customer relationships with useful lives ranging between 10 and 20 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Net sales for Agrolux included within the Hawthorne segment for the three and six months ended March 31, 2018 were $5.3 million and $26.0 million, respectively.
On October 3, 2016, the Company’s Hawthorne segment completed the acquisition of American Agritech, L.L.C., d/b/a Botanicare (“Botanicare”), an Arizona-based leading producer of plant nutrients, plant supplements and growing systems used for hydroponic gardening, for $92.6 million. The purchase price included contingent consideration, a non-cash investing activity, of $15.5 million, which was paid during the third quarter of fiscal 2017. The valuation of the acquired assets included (i) $1.2 million of cash, prepaid and other current assets, (ii) $8.4 million of inventory and accounts receivable, (iii) $1.4 million of fixed assets, (iv) $2.3 million of accounts payable and other current liabilities, (v) $53.0 million of finite-lived identifiable intangible assets, and (vi) $30.9 million of tax-deductible goodwill. Identifiable intangible assets included tradenames, customer relationships and non-compete arrangements with useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Net sales for Botanicare included within the Hawthorne segment for the three and six months ended March 31, 2018 were $8.1 million and $15.2 million, respectively, as compared to $11.3 million and $21.2 million for the three and six months ended April 1, 2017, respectively.
During the first quarter of fiscal 2017, the Company’s U.S. Consumer segment completed two acquisitions of companies whose products support the Company’s focus on the emerging areas of water positive landscapes and internet-enabled technology for an aggregate purchase price of $3.2 million. The valuation of the acquired assets for the transactions included finite-lived identifiable intangible assets and goodwill of $2.8 million. During the third quarter of fiscal 2017, the Company’s Hawthorne segment completed the acquisition of a company focused on the technology supporting hydroponic growing systems for an aggregate purchase price of $3.5 million, which included finite-lived identifiable intangible assets of $3.2 million.

13
Table of Contents

NOTE 4. INVESTMENT IN UNCONSOLIDATED AFFILIATES
As of March 31, 2018, the Company held a minority equity interest of approximately 30% in the TruGreen Joint Venture. In addition, the Company and TruGreen Holdings are parties to a limited liability company agreement (the “LLC Agreement”) governing the management of the TruGreen Joint Venture, as well as certain ancillary agreements including a transition services agreement. The LLC Agreement provides the Company with minority representation on the board of directors of the TruGreen Joint Venture. The Company’s interest had an initial fair value of $294.0 million and was previously accounted for using the equity method of accounting, with the Company’s proportionate share of the TruGreen Joint Venture earnings reflected in the Condensed Consolidated Statements of Operations. In the first quarter of fiscal 2018, the Company discontinued applying the equity method of accounting for the TruGreen Joint Venture as the Company’s net investment and advances were reduced to a liability. The Company does not have any contractual obligations to fund losses of the TruGreen Joint Venture.
In connection with the closing of the transactions contemplated by the Contribution Agreement on April 13, 2016, the Company invested $18.0 million in second lien term loan financing to the TruGreen Joint Venture. The second lien term loan receivable had a carrying value of $18.1 million and $18.0 million at March 31, 2018 and April 1, 2017, respectively, and is recorded in the “Other assets” line in the Condensed Consolidated Balance Sheets. The Company was reimbursed $0.1 million and $0.6 million during the three and six months ended March 31, 2018, respectively, and had accounts receivable of $0.5 million at March 31, 2018 for expenses incurred pursuant to a short-term transition services agreement. The Company did not receive distributions from unconsolidated affiliates during the three and six months ended March 31, 2018. The Company was reimbursed $14.7 million and $33.7 million during the three and six months ended April 1, 2017, respectively, and had accounts receivable of $8.3 million at April 1, 2017 for expenses incurred pursuant to a short-term transition services agreement and an employee leasing agreement. The Company received distributions from unconsolidated affiliates intended to cover required tax payments of zero and $2.2 million during the three and six months ended April 1, 2017, respectively. The Company also had an indemnification asset of $4.2 million and $7.4 million at March 31, 2018 and April 1, 2017, respectively, for future payments on claims associated with insurance programs. The Company has received cumulative distributions from the TruGreen Joint Venture in excess of its investment balance, which resulted in an amount recorded in the “Distributions in excess of investment in unconsolidated affiliate” line in the Condensed Consolidated Balance Sheets of $21.9 million at March 31, 2018. In accordance with the applicable accounting guidance, the Company reclassified the negative balance to the liability section of the Condensed Consolidated Balance Sheet. 
During the fourth quarter of fiscal 2017, the Company made a $29.4 million investment in an unconsolidated subsidiary whose products support the professional U.S. industrial, turf and ornamental market (the “IT&O Joint Venture”). During the three and six months ended March 31, 2018, respectively, the Company invested $2.1 million and $7.4 million in line of credit financing to the IT&O Joint Venture, which is recorded in the “Other assets” line in the Condensed Consolidated Balance Sheets.
The following table presents summarized financial information of the Company’s unconsolidated affiliates:
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
 
(In millions)
Revenue
$
175.7

 
$
154.7

 
$
447.9

 
$
406.8

Gross margin
8.4

 
9.7

 
84.4

 
70.8

Selling and administrative expenses
52.4

 
51.5

 
116.4

 
92.9

Amortization expense
10.3

 
21.7

 
22.4

 
41.9

Interest expense
18.0

 
16.6

 
35.5

 
33.5

Restructuring and other charges
8.3

 
—

 
11.9

 
26.6

Net income (loss)
$
(80.6
)
 
$
(80.1
)
 
$
(101.8
)
 
$
(124.1
)
Due to the seasonal nature of the lawn, tree and shrub care business, the TruGreen Joint Venture anticipates a net loss during the Company’s first and second fiscal quarters. Net income (loss) does not include income taxes, which are recognized and paid by the partners of the unconsolidated affiliates. The income taxes associated with the Company’s share of net income (loss) have been recorded in the “Income tax expense (benefit) from continuing operations” line in the Condensed Consolidated Statements of Operations.
The Company recognized equity in (income) loss of unconsolidated affiliates of $(1.5) million and $(2.1) million for the three and six months ended March 31, 2018, respectively, as compared to $24.1 million and $37.3 million and for the three and six months ended April 1, 2017, respectively. The Company’s share of restructuring and other charges incurred by the TruGreen Joint Venture was $2.1 million and $11.7 million for the three and six months ended April 1, 2017, respectively. For the three and six months ended April 1, 2017, these charges included zero and $7.9 million, respectively, for nonrecurring integration and

14
Table of Contents

separation costs and $2.1 million and $3.8 million, respectively, for a non-cash purchase accounting fair value write-down adjustment related to deferred revenue and advertising.
NOTE 5. IMPAIRMENT, RESTRUCTURING AND OTHER
Activity described herein is classified within the “Impairment, restructuring and other” and “Income (loss) from discontinued operations, net of tax” lines in the Condensed Consolidated Statements of Operations.
The following table details impairment, restructuring and other charges for each of the periods presented:
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
 
(In millions)
Operating expenses:
 
 
 
 
 
 
 
Restructuring and other charges
$
10.2

 
$
1.0

 
$
10.0

 
$
0.8

Impairment, restructuring and other charges from continuing operations
$
10.2

 
$
1.0

 
$
10.0

 
$
0.8

Restructuring and other charges from discontinued operations
0.2

 
2.4

 
1.6

 
4.6

Total impairment, restructuring and other charges
$
10.4

 
$
3.4

 
$
11.6

 
$
5.4

The following table summarizes the activity related to liabilities associated with restructuring and other, excluding insurance reimbursement recoveries, during the six months ended March 31, 2018 (in millions):
Amounts accrued for restructuring and other at September 30, 2017
$
12.1

Restructuring and other charges from continuing operations
10.0

Restructuring and other charges from discontinued operations
1.6

Payments and other
(6.4
)
Amounts accrued for restructuring and other at March 31, 2018
$
17.3

Included in restructuring accruals, as of March 31, 2018, is $1.1 million that is classified as long-term. Payments against the long-term accruals will be incurred as the employees covered by the restructuring plan retire or through the passage of time. The remaining amounts accrued will continue to be paid out over the course of the next twelve months.
During the three months ended March 31, 2018, the Company recognized a charge of $10.2 million for a probable loss on a previously disclosed legal matter within the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. Refer to “NOTE 12. CONTINGENCIES” for more information.
In the first quarter of fiscal 2016, the Company announced a series of initiatives called Project Focus designed to maximize the value of its non-core assets and focus on emerging categories of the lawn and garden industry in its core U.S. business. During the three and six months ended March 31, 2018, the Company’s U.S. Consumer segment recognized adjustments of $0.1 million and $0.3 million, respectively, related to previously recognized termination benefits in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. During the three and six months ended April 1, 2017, the Company’s U.S. Consumer segment recognized charges of $1.0 million and $0.8 million, respectively, related to termination benefits in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. Costs incurred to date since the inception of the current Project Focus initiatives are $9.8 million for the U.S. Consumer segment, $1.0 million for the Hawthorne segment and $1.2 million for the Other segment, related to transaction activity, termination benefits and facility closure costs.
On April 13, 2016, as part of Project Focus, the Company completed the contribution of the SLS Business to the TruGreen Joint Venture. Refer to “NOTE 2. DISCONTINUED OPERATIONS” for more information. During the three and six months ended April 1, 2017, the Company recognized $0.1 million and $0.7 million, respectively, in transaction related costs associated with the divestiture of the SLS Business in the “Income (loss) from discontinued operations, net of tax” line in the Condensed Consolidated Statements of Operations.
On August 31, 2017, the Company completed the sale of the International Business. As a result, effective in its fourth quarter of fiscal 2017, the Company classified its results of operations for all periods presented to reflect the International Business as a discontinued operation and classified the assets and liabilities of the International Business as held for sale. Refer to “NOTE 2. DISCONTINUED OPERATIONS” for more information. During the three and six months ended March 31, 2018, the Company recognized $0.2 million and $1.6 million, respectively, as compared to $2.3 million and $3.9 million for the three and six months ended April 1, 2017, respectively, in transaction related costs associated with the sale of the International Business in the “Income (loss) from discontinued operations, net of tax” line in the Condensed Consolidated Statements of Operations.

15
Table of Contents

NOTE 6. INVENTORIES
Inventories consisted of the following for each of the periods presented:
 
MARCH 31,
2018
 
APRIL 1,
2017
 
SEPTEMBER 30,
2017
 
(In millions)
Finished goods
$
395.8

 
$
403.8

 
$
210.6

Work-in-process
61.2

 
51.5

 
57.6

Raw materials
139.9

 
141.2

 
139.3

Total inventories
$
596.9

 
$
596.5

 
$
407.5


Adjustments to reflect inventories at net realizable values were $11.9 million at March 31, 2018, $7.6 million at April 1, 2017 and $10.5 million at September 30, 2017.
NOTE 7. MARKETING AGREEMENT
The Scotts Company LLC (“Scotts LLC”) is the exclusive agent of Monsanto for the marketing and distribution of consumer Roundup® non-selective weedkiller products in the consumer lawn and garden market in certain countries pursuant to an Amended and Restated Exclusive Agency and Marketing Agreement (the “Original Marketing Agreement”). In consideration for the rights granted to the Company under the Original Marketing Agreement in 1998, the Company paid a marketing fee of $32.0 million to Monsanto. The Company deferred this amount on the basis that the payment will provide a future benefit through commissions that will be earned under the Marketing Agreement. The economic useful life over which the marketing fee is being amortized is 20 years, with a remaining unamortized amount of $0.4 million and remaining amortization period of less than one year. On May 15, 2015, the Company and Monsanto entered into an Amendment to the Original Marketing Agreement (the “Marketing Agreement Amendment”), a Lawn and Garden Brand Extension Agreement (the “Brand Extension Agreement”) and a Commercialization and Technology Agreement (the “Commercialization and Technology Agreement”). In consideration for these agreements, the Company paid $300.0 million to Monsanto and recorded this amount as intangible assets for which the related economic useful life is indefinite.
On August 31, 2017, in connection with and as a condition to the consummation of the Company’s sale of its International Business, the Company entered into the Second Amended and Restated Agency and Marketing Agreement (the “Restated Marketing Agreement”) and the Amended and Restated Lawn and Garden Brand Extension Agreement - Americas (the “Restated Brand Extension Agreement”) to reflect the Company’s transfer and assignment to the purchaser of such business of the Company’s rights and responsibilities under the Original Marketing Agreement, as amended, and the Brand Extension Agreement relating to those countries subject to the sale. The Company included $32.6 million of the carrying amount of the intangible asset associated with the Marketing Agreement Amendment with the International Business disposal unit on the basis of the asset’s historical carrying amount and this amount was disposed of as part of the sale of the International Business.
From 1998 until May 15, 2015, the Original Marketing Agreement covered the United States and other specified countries, including Australia, Austria, Belgium, Canada, France, Germany, the Netherlands and the United Kingdom. The Marketing Agreement Amendment expanded the covered territories and countries to include all countries other than Japan and countries subject to a comprehensive U.S. trade embargo or certain other embargoes and trade restrictions. The Restated Marketing Agreement further revised the covered territories and countries to only include Israel, China and every country throughout the Caribbean and the continents of North America and South America that is not subject to a comprehensive U.S. trade embargo or certain other embargoes and trade restrictions.
Under the terms of the Restated Marketing Agreement, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The annual commission payable under the Restated Marketing Agreement is equal to (1) 50% of the actual earnings before interest and income taxes of the consumer Roundup® business in the markets covered by the Restated Marketing Agreement for program years 2017 and 2018 and (2) 50% of the actual earnings before interest and income taxes of the consumer Roundup® business in the markets covered by the Restated Marketing Agreement in excess of $40 million for program years 2019 and thereafter. The Restated Marketing Agreement also requires the Company to make annual payments of $18.0 million to Monsanto as a contribution against the overall expenses of the consumer Roundup® business. Unless Monsanto terminates the Restated Marketing Agreement due to an event of default by the Company, the Restated Marketing Agreement requires a termination fee payable to the Company equal to the greater of (1) $175.0 million or (2) four times (A) the average of the program earnings before interest and income taxes for the three trailing program years prior to the year of termination, minus (B) $186.4 million. The term of the Restated Marketing Agreement will continue indefinitely for all included markets unless and until otherwise terminated in accordance therewith.

16
Table of Contents

The Restated Brand Extension Agreement provides the Company an exclusive license in every country throughout the North American continent, South American continent, Central America, the Caribbean, Israel and China (in each case that is not subject to a comprehensive U.S. trade embargo or certain other embargoes and trade restrictions) to use the Roundup® brand on additional products offered by the Company outside of the non-selective weed category within the residential lawn and garden market. The application of the Roundup® brand to these additional products is subject to a product review and approval process developed between the Company and Monsanto. Monsanto will maintain oversight of its brand, the handling of brand registrations covering these new products and new territories, as well as primary responsibility for brand enforcement. The Restated Brand Extension Agreement has a term of twenty years, which will automatically renew for additional successive twenty year terms, at the Company’s sole option, for no additional monetary consideration.
The Commercialization and Technology Agreement provides for the Company and Monsanto to further develop and commercialize new products and technology developed at Monsanto and intended for introduction into the residential lawn and garden market. Under the Commercialization and Technology Agreement, the Company receives an exclusive first look at new Monsanto technology and products and an annual review of Monsanto’s developing products and technologies. The Commercialization and Technology Agreement has a term of thirty years (subject to early termination upon a termination event under the Restated Marketing Agreement or the Restated Brand Extension Agreement).
Under the terms of the Restated Marketing Agreement, the Company performs sales, merchandising, warehousing and other selling and marketing services, on behalf of Monsanto in the conduct of the consumer Roundup® business. The Company performs other services, including manufacturing conversion services, pursuant to ancillary agreements. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Condensed Consolidated Statements of Operations, with no effect on gross profit dollars or net income.
The gross commission earned under the Restated Marketing Agreement, the contribution payments to Monsanto and the amortization of the initial marketing fee paid to Monsanto in 1998 are included in the calculation of net sales in the Company’s Condensed Consolidated Statements of Operations. The elements of the net commission and reimbursements earned under the Marketing Agreement and included in “Net sales” are as follows:
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
 
(In millions)
Gross commission
$
34.5

 
$
41.1

 
$
34.6

 
$
42.3

Contribution expenses
(4.5
)
 
(4.5
)
 
(9.0
)
 
(9.0
)
Amortization of marketing fee
(0.2
)
 
(0.2
)
 
(0.4
)
 
(0.4
)
Net commission
29.8

 
36.4

 
25.2

 
32.9

Reimbursements associated with Marketing Agreement
19.7

 
19.4

 
32.5

 
33.6

Total net sales associated with Marketing Agreement
$
49.5

 
$
55.8

 
$
57.7

 
$
66.5



17
Table of Contents

NOTE 8. DEBT
The components of debt are as follows:
 
MARCH 31,
2018
 
APRIL 1,
2017
 
SEPTEMBER 30,
2017
 
(In millions)
Credit Facilities:
 
 
 
 
 
Revolving loans
$
1,043.2

 
$
1,096.8

 
$
300.5

Term loans
266.3

 
281.3

 
273.8

Senior Notes – 5.250%
250.0

 
250.0

 
250.0

Senior Notes – 6.000%
400.0

 
400.0

 
400.0

Receivables facility
300.0

 
—

 
80.0

Other
22.0

 
56.1

 
105.4

Total debt
2,281.5

 
2,084.2

 
1,409.7

Less current portions
335.8

 
32.1

 
143.1

Less unamortized debt issuance costs
8.0

 
9.2

 
8.6

Long-term debt
$
1,937.7

 
$
2,042.9

 
$
1,258.0

Credit Facilities
On October 29, 2015, the Company entered into the fourth amended and restated credit agreement (the “credit agreement”), which provides the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $1.9 billion that are comprised of a revolving credit facility of $1.6 billion and a term loan in the original principal amount of $300.0 million (the “credit facilities”). The credit agreement also provides the Company with the right to seek additional committed credit under the agreement in an aggregate amount of up to $500.0 million plus an unlimited additional amount, subject to certain specified financial and other conditions. Under the credit agreement, the Company has the ability to obtain letters of credit up to $100.0 million. The credit agreement will terminate on October 29, 2020. Borrowings on the revolving credit facility may be made in various currencies, including U.S. dollars, euro, British pounds, Australian dollars and Canadian dollars. The terms of the credit agreement include customary representations and warranties, affirmative and negative covenants, financial covenants and events of default. The proceeds of borrowings on the credit facilities may be used: (i) to finance working capital requirements and other general corporate purposes of the Company and its subsidiaries; and (ii) to refinance the amounts outstanding under the Company’s former credit facility.
Under the terms of the credit agreement, loans bear interest, at the Company’s election, at a rate per annum equal to either the ABR or Adjusted LIBO Rate (both as defined in the credit agreement) plus the applicable margin. The credit facilities are guaranteed by substantially all of the Company’s domestic subsidiaries, and are secured by (i) a perfected first priority security interest in all of the accounts receivable, inventory and equipment of the Company and the Company’s domestic subsidiaries that are guarantors and (ii) the pledge of all of the capital stock of the Company’s domestic subsidiaries that are guarantors.
At March 31, 2018, the Company had letters of credit outstanding in the aggregate principal amount of $22.2 million, and $534.6 million of availability under the credit agreement, subject to the Company’s continued compliance with the covenants discussed below. The weighted average interest rates on average borrowings under the credit agreement were 4.1% and 3.7% for the six months ended March 31, 2018 and April 1, 2017, respectively.
The credit agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio on the last day of each quarter calculated as average total indebtedness, divided by the Company’s earnings before interest, taxes, depreciation and amortization (“EBITDA”), as adjusted pursuant to the terms of the credit agreement (“Adjusted EBITDA”). The maximum leverage ratio was 4.50 as of March 31, 2018. The Company’s leverage ratio was 3.46 at March 31, 2018. The credit agreement also includes an affirmative covenant regarding its interest coverage ratio. The interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as described in the credit agreement, and excludes costs related to refinancings. The minimum interest coverage ratio was 3.00 for the twelve months ended March 31, 2018. The Company’s interest coverage ratio was 6.70 for the twelve months ended March 31, 2018. The credit agreement allows the Company to make unlimited restricted payments (as defined in the credit agreement), including increased or one-time dividend payments and Common Share repurchases, as long as the leverage ratio resulting from the making of such restricted payments is 4.00 or less. Otherwise the Company may only make restricted payments in an aggregate amount for each fiscal year not to exceed $200.0 million.

18
Table of Contents

Senior Notes - 5.250%
On December 15, 2016, Scotts Miracle-Gro issued $250.0 million aggregate principal amount of 5.250% senior notes due 2026 (the “5.250% Senior Notes”). The net proceeds of the offering were used to repay outstanding borrowings under the credit facilities. The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year. The 5.250% Senior Notes may be redeemed, in whole or in part, on or after December 15, 2021 at applicable redemption premiums. The 5.250% Senior Notes contain customary covenants and events of default and mature on December 15, 2026. Substantially all of Scotts Miracle-Gro’s domestic subsidiaries serve as guarantors of the 5.250% Senior Notes.
Senior Notes - 6.000%
On October 13, 2015, Scotts Miracle-Gro issued $400.0 million aggregate principal amount of 6.000% senior notes due 2023 (the “6.000% Senior Notes”). The net proceeds of the offering were used to repay outstanding borrowings under the credit agreement. The 6.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 6.000% Senior Notes have interest payment dates of April 15 and October 15 of each year. The 6.000% Senior Notes may be redeemed, in whole or in part, on or after October 15, 2018 at applicable redemption premiums. The 6.000% Senior Notes contain customary covenants and events of default and mature on October 15, 2023. Substantially all of Scotts Miracle-Gro’s domestic subsidiaries serve as guarantors of the 6.000% Senior Notes.
Receivables Facility
On September 25, 2015, the Company entered into an amended and restated master accounts receivable purchase agreement (the “MARP Agreement”). The MARP Agreement provided for the discretionary sale by the Company, and the discretionary purchase by the participating banks, on a revolving basis, of accounts receivable generated by sales to three specified debtors in an aggregate amount not to exceed $400.0 million. The MARP Agreement terminated effective October 14, 2016 in accordance with its terms upon the Company’s repayment of its outstanding obligations thereunder using $133.5 million borrowed under the credit agreement.
On April 7, 2017, the Company entered into a Master Repurchase Agreement (including the annexes thereto, the “Repurchase Agreement”) and a Master Framework Agreement (the “Framework Agreement” and, together with the Repurchase Agreement, the “Receivables Facility”). Under the Receivables Facility, the Company may sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers and simultaneously agrees to repurchase the receivables on a weekly basis. The eligible accounts receivable consist of up to $250.0 million in accounts receivable generated by sales to three specified customers. The Receivables Facility is considered a secured financing with the customer accounts receivable, related contract rights and proceeds thereof (and the collection accounts into which the same are deposited) constituting the collateral therefor. The repurchase price for customer accounts receivable bears interest at LIBOR (with a zero floor), as defined in the Repurchase Agreement, plus 0.90%.
On August 25, 2017, the Company entered into Amendment No. 1 to Master Framework Agreement (the “Amendment”). The Amendment (i) extends the expiration date of the Receivables Facility from August 25, 2017 to August 24, 2018, (ii) defines the seasonal commitment period of the Receivables Facility as beginning on February 23, 2018 and ending on June 15, 2018, (iii) increases the eligible amount of customer accounts receivable which may be sold from up to $250.0 million to up to $400.0 million and (iv) increases the commitment amount of the Receivables Facility during the seasonal commitment period from up to $100.0 million to up to $160.0 million.
The Company accounts for the sale of receivables under the Receivables Facility as short-term debt and continues to carry the receivables on its Condensed Consolidated Balance Sheet, primarily as a result of the Company’s requirement to repurchase receivables sold. There were $300.0 million in borrowings on receivables pledged as collateral under the Receivables Facility as of March 31, 2018. The carrying value of the receivables pledged as collateral was $333.3 million as of March 31, 2018. As of March 31, 2018, there was $78.4 million of availability under the Receivables Facility.
Other
In connection with the acquisition of a controlling interest in Gavita during fiscal 2016, the Company recorded a loan to the noncontrolling ownership group of Gavita. On October 2, 2017, the Company’s Hawthorne segment acquired the remaining 25% noncontrolling interest in Gavita, which included extinguishment of the loan to the noncontrolling ownership group of Gavita with a fair value and carrying value of $55.6 million. The fair value of the loan was $37.2 million and $55.6 million at April 1, 2017 and September 30, 2017, respectively.

19
Table of Contents

Interest Rate Swap Agreements
The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a maximum total U.S. dollar equivalent notional amount of $1,300.0 million at March 31, 2018, $1,150.0 million at April 1, 2017 and $1,100.0 million at September 30, 2017, respectively. Interest payments made between the effective date and expiration date are hedged by the swap agreements, except as noted below.
The notional amount, effective date, expiration date and rate of each of these swap agreements outstanding at March 31, 2018 are shown in the table below:
Notional Amount
(in millions)
 
Effective
Date (a)
 
Expiration
Date
 
Fixed
Rate
$
300

(b) 
11/21/2016
 
6/20/2018
 
0.83
%
200

(b)  
11/7/2016
 
8/7/2018
 
0.84
%
150

(c)  
2/7/2017
 
5/7/2019
 
2.12
%
50

(c) 
2/7/2017
 
5/7/2019
 
2.25
%
50

 
2/28/2018
 
5/28/2019
 
2.01
%
200

(d) 
12/20/2016
 
6/20/2019
 
2.12
%
250

(b)  
1/8/2018
 
6/8/2020
 
2.09
%
100

 
6/20/2018
 
10/20/2020
 
2.15
%

(a)
The effective date refers to the date on which interest payments were first hedged by the applicable swap agreement.
(b)
Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.
(c)
Interest payments made during the three-month period of each year that begins with the month and day of the effective date are hedged by the swap agreement.
(d)
Interest payments made during the six-month period of each year that begins with the month and day of the effective date are hedged by the swap agreement.
Estimated Fair Values
The methods and assumptions used to estimate the fair values of the Company’s debt instruments are described below:
Credit Facilities
The interest rate currently available to the Company fluctuates with the applicable LIBO rate, prime rate or Federal Funds Effective Rate and thus the carrying value is a reasonable estimate of fair value. The fair value measurement for the credit facilities was classified in Level 2 of the fair value hierarchy.
5.250% Senior Notes
The fair value of the 5.250% Senior Notes was determined based on the trading of the 5.250% Senior Notes in the open market. The difference between the carrying value and the fair value of the 5.250% Senior Notes represents the premium or discount on that date. Based on the trading value on or around March 31, 2018, the fair value of the 5.250% Senior Notes was approximately $247.5 million. The fair value measurement for the 5.250% Senior Notes was classified in Level 1 of the fair value hierarchy.
6.000% Senior Notes
The fair value of the 6.000% Senior Notes was determined based on the trading of the 6.000% Senior Notes in the open market. The difference between the carrying value and the fair value of the 6.000% Senior Notes represents the premium or discount on that date. Based on the trading value on or around March 31, 2018, the fair value of the 6.000% Senior Notes was approximately $419.0 million. The fair value measurement for the 6.000% Senior Notes was classified in Level 1 of the fair value hierarchy.
Accounts Receivable Pledged
The interest rate on the short-term debt associated with accounts receivable pledged under the Receivables Facility fluctuated with the applicable LIBOR and thus the carrying value is a reasonable estimate of fair value. The fair value measurement for the Receivables Facility was classified in Level 2 of the fair value hierarchy.

20
Table of Contents

Weighted Average Interest Rate
The weighted average interest rates on the Company’s debt were 4.4% and 4.3% for the six months ended March 31, 2018 and April 1, 2017, respectively.
NOTE 9. RETIREMENT AND RETIREE MEDICAL PLANS
The following summarizes the components of net periodic benefit (income) cost for the retirement and retiree medical plans sponsored by the Company: 
 
THREE MONTHS ENDED
 
MARCH 31, 2018
 
APRIL 1, 2017
 
U.S.
Pension
 
International
Pension
 
U.S.
Medical
 
U.S.
Pension
 
International
Pension
 
U.S.
Medical
 
(In millions)
Service cost
$
—

 
$
0.3

 
$
0.1

 
$
—

 
$
0.2

 
$
0.1

Interest cost
0.7

 
1.1

 
0.2

 
0.7

 
1.0

 
0.1

Expected return on plan assets
(1.1
)
 
(2.1
)
 
—

 
(1.2
)
 
(2.0
)
 
—

Net amortization
0.4

 
0.3

 
(0.3
)
 
0.4

 
0.4

 
(0.2
)
Net periodic benefit (income) cost
$
—

 
$
(0.4
)
 
$
—

 
$
(0.1
)
 
$
(0.4
)
 
$
—

 
SIX MONTHS ENDED
 
MARCH 31, 2018
 
APRIL 1, 2017
 
U.S.
Pension
 
International
Pension
 
U.S.
Medical
 
U.S.
Pension
 
International
Pension
 
U.S.
Medical
 
(In millions)
Service cost
$
—

 
$
0.5

 
$
0.2

 
$
—

 
$
0.4

 
$
0.2

Interest cost
1.5

 
2.1

 
0.3

 
1.4

 
1.9

 
0.3

Expected return on plan assets
(2.3
)
 
(4.1
)
 
—

 
(2.4
)
 
(3.9
)
 
—

Net amortization
0.8

 
0.6

 
(0.5
)
 
0.8

 
0.9

 
(0.4
)
Net periodic benefit (income) cost
$
—

 
$
(0.9
)
 
$
—

 
$
(0.2
)
 
$
(0.7
)
 
$
0.1


21
Table of Contents

NOTE 10. EQUITY
The following table provides a summary of the changes in total equity, equity attributable to controlling interest, and equity attributable to noncontrolling interests for the six months ended March 31, 2018 and April 1, 2017 (in millions):
 
Common Shares and Capital in
Excess of Stated Value
 
Retained
Earnings
 
Treasury
Shares
 
Accumulated Other
Comprehensive Loss
 
Total Equity -
Controlling Interest
 
Non-controlling
Interest
 
Total
Equity
Balance at September 30, 2016
$
401.7

 
$
881.8

 
$
(451.4
)
 
$
(116.9
)
 
$
715.2

 
$
19.1

 
$
734.3

Net income (loss)
—

 
99.8

 
—

 
—

 
99.8

 
0.5

 
100.3

Other comprehensive income (loss)
—

 
—

 
—

 
3.2

 
3.2

 
—

 
3.2

Share-based compensation
19.1

 
—

 
—

 
—

 
19.1

 
—

 
19.1

Dividends declared ($1.00 per share)
—

 
(60.6
)
 
—

 
—

 
(60.6
)
 
—

 
(60.6
)
Treasury share purchases
—

 
—

 
(90.6
)
 
—

 
(90.6
)
 
—

 
(90.6
)
Treasury share issuances
(20.0
)
 
—

 
13.8

 
—

 
(6.2
)
 
—

 
(6.2
)
Adjustment to noncontrolling interest due to ownership change
(1.0
)
 
—

 
—

 
—

 
(1.0
)
 
1.0

 
—

Distribution declared by AeroGrow
—

 
—

 
—

 
—

 
—

 
(8.1
)
 
(8.1
)
Balance at April 1, 2017
$
399.8

 
$
921.0

 
$
(528.2
)
 
$
(113.7
)
 
$
678.9

 
$
12.5

 
$
691.4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at September 30, 2017
$
407.6

 
$
978.2

 
$
(667.8
)
 
$
(69.2
)
 
$
648.8

 
$
12.9

 
$
661.7

Net income (loss)
—

 
127.7

 
—

 
—

 
127.7

 
0.1

 
127.8

Other comprehensive income (loss)
—

 
—

 
—

 
17.9

 
17.9

 
—

 
17.9

Share-based compensation
15.7

 
—

 
—

 
—

 
15.7

 
—

 
15.7

Dividends declared ($1.06 per share)
—

 
(61.4
)
 
—

 
—

 
(61.4
)
 
—

 
(61.4
)
Treasury share purchases
—

 
—

 
(256.8
)
 
—

 
(256.8
)
 
—

 
(256.8
)
Treasury share issuances
(8.6
)
 
—

 
13.2

 
—

 
4.6

 
—

 
4.6

Acquisition of remaining noncontrolling interest in Gavita
(5.7
)
 
—

 
—

 
—

 
(5.7
)
 
(7.9
)
 
(13.6
)
Balance at March 31, 2018
$
409.0

 
$
1,044.5

 
$
(911.4
)
 
$
(51.3
)
 
$
490.8

 
$
5.1

 
$
495.9

Accumulated Other Comprehensive Loss
During the three months ended March 31, 2018, the Company repatriated cash from a foreign subsidiary resulting in the liquidation of substantially all of the assets of the subsidiary and the write-off of accumulated foreign currency translation loss adjustments of $11.7 million within the “Other non-operating expense, net” line in the Condensed Consolidated Statements of Operations.
Share Repurchases
In August 2014, the Scotts Miracle-Gro Board of Directors authorized the repurchase of up to $500.0 million of Common Shares over a five-year period (effective November 1, 2014 through September 30, 2019). On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors authorized a $500.0 million increase to the share repurchase authorization ending on September 30, 2019. The amended authorization allows for repurchases of Common Shares of up to $1.0 billion through September 30, 2019. The authorization provides the Company with flexibility to purchase Common Shares from time to time in open market purchases or through privately negotiated transactions. All or part of the repurchases may be made under Rule 10b5-1 plans, which the Company may enter into from time to time and which enable the repurchases to occur on a more regular basis, or pursuant to accelerated share repurchases. The share repurchase authorization, which expires September 30, 2019, may be suspended or discontinued at any time, and there can be no guarantee as to the timing or amount of any repurchases. During the three and six months ended March 31, 2018, Scotts Miracle-Gro repurchased 1.7 million and 2.7 million Common Shares for $160.2 million and $256.8 million, respectively. From the inception of this share repurchase program in the fourth quarter of fiscal 2014 through March 31, 2018, Scotts Miracle-Gro repurchased approximately 7.5 million Common Shares for $648.3 million.
Exercise of Outstanding AeroGrow Warrants
On November 29, 2016, the Company’s wholly-owned subsidiary SMG Growing Media, Inc. fully exercised its outstanding warrants to acquire additional shares of common stock of AeroGrow for an aggregate warrant exercise price of $47.8 million in

22
Table of Contents

exchange for the issuance of 21.6 million shares of common stock of AeroGrow, which increased the Company’s percentage ownership of AeroGrow’s outstanding shares of common stock (on a fully diluted basis) from 45% to 80%. The financial results of AeroGrow have been consolidated into the Company’s consolidated financial statements since the fourth quarter of fiscal 2014, when the Company obtained control of AeroGrow’s operations through increased involvement, influence and a working capital loan provided to AeroGrow. Following the exercise of the warrants, the Board of Directors of AeroGrow declared a $40.5 million distribution ($1.21 per share) payable on January 3, 2017 to shareholders of record on December 20, 2016. On January 3, 2017, AeroGrow paid a distribution of $8.1 million to its noncontrolling interest holders.
Share-Based Awards
Scotts Miracle-Gro grants share-based awards annually to officers and certain other employees of the Company and non-employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock units, deferred stock units and performance-based awards. All of these share-based awards have been made under plans approved by the shareholders of Scotts Miracle-Gro. If available, Scotts Miracle-Gro will typically use treasury shares, or if not available, newly-issued Common Shares, in satisfaction of its share-based awards.
On October 30, 2017, the Company issued 0.2 million upfront performance-based award units, covering a four-year performance period, with an estimated fair value of $20.2 million on the date of grant to certain Hawthorne segment employees as part of its Project Focus initiative. These awards vest after approximately four years subject to the achievement of specific performance goals aligned with the strategic objectives of the Company’s Project Focus initiatives. Based on the extent to which the performance goals are achieved, vested shares may range from 50 to 250 percent of the target award amount. The performance goals are based on cumulative Hawthorne non-GAAP adjusted earnings. Performance-based award units accrue cash dividend equivalents that are payable upon vesting of the awards.
The following is a summary of the share-based awards granted during each of the periods indicated:
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
Employees
 
 
 
Restricted stock units
109,563

 
102,143

Performance units
235,503

 
487,674

Board of Directors
 
 
 
Deferred stock units
20,799

 
22,902

Total share-based awards
365,865

 
612,719

 
 
 
 
Aggregate fair value at grant dates (in millions)
$
34.9

 
$
56.9

Total share-based compensation was as follows for each of the periods indicated:
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
 
(In millions)
Share-based compensation
$
9.7

 
$
12.8

 
$
15.7

 
$
15.1

Tax benefit recognized
1.8

 
4.9

 
4.1

 
5.8


23
Table of Contents

Stock Options
Aggregate stock option activity was as follows: 
 
No. of
  Options
 
Wtd.
Avg.
Exercise
Price
Awards outstanding at September 30, 2017
1,517,310

 
$
53.05

Granted
—

 
—

Exercised
(72,027
)
 
50.38

Forfeited
(1,367
)
 
36.86

Awards outstanding at March 31, 2018
1,443,916

 
53.20

Exercisable
1,017,603

 
$
46.72

At March 31, 2018, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was $0.6 million, which is expected to be recognized over a weighted-average period of 0.8 years. The intrinsic value of stock options exercised for the six months ended March 31, 2018 was $3.8 million. At March 31, 2018, the Company expects 0.4 million of the remaining unexercisable stock options (after forfeitures), with a weighted-average exercise price of $68.65, intrinsic value of $7.1 million and average remaining term of 7.8, to vest in the future. The following summarizes certain information pertaining to stock option awards outstanding and exercisable at March 31, 2018 (options in millions): 
 
 
Awards Outstanding
 
Awards Exercisable
Range of
Exercise Price
 
No. of
Options
 
Wtd.
Avg.
Remaining
Life
 
Wtd.
Avg.
Exercise
Price
 
No. of
Options
 
Wtd.
Avg.
Remaining
Life
 
Wtd.
Avg.
Exercise
Price
$20.59 – $20.59
 
0.2

 
0.51
 
$
20.59

 
0.2

 
0.51
 
$
20.59

$38.81 – $49.19
 
0.4

 
2.93
 
45.22

 
0.4

 
2.93
 
45.22

$63.43 – $68.68
 
0.8

 
7.36
 
66.26

 
0.4

 
6.84
 
63.49

 
 
1.4

 
5.02
 
$
53.20

 
1.0

 
3.84
 
$
46.72

 
The intrinsic values of the stock option awards outstanding and exercisable at March 31, 2018 were as follows (in millions): 
Outstanding
$
47.0

Exercisable
39.7

Restricted share-based awards
Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:
 
No. of
Shares
 
Wtd. Avg.
Grant Date
Fair Value
per Share
Awards outstanding at September 30, 2017
291,519

 
$
81.15

Granted
130,362

 
90.86

Vested
(86,601
)
 
67.70

Forfeited
—

 
—

Awards outstanding at March 31, 2018
335,280

 
$
88.39

 
At March 31, 2018, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was $8.3 million, which is expected to be recognized over a weighted-average period of 1.9 years.

24
Table of Contents

Performance-based awards
Performance-based award activity was as follows (based on target award amounts):
 
No. of
Units
 
Wtd. Avg.
Grant Date
Fair Value
per Unit
Awards outstanding at September 30, 2017
596,933

 
$
88.01

Granted
235,503

 
97.72

Vested
(53,644
)
 
63.43

Forfeited
(3,037
)
 
98.81

Awards outstanding at March 31, 2018
775,755

 
$
92.61

At March 31, 2018, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based units not yet recognized was $28.0 million, which is expected to be recognized over a weighted-average period of 3.3 years.
NOTE 11. INCOME TAXES
On December 22, 2017, H.R.1 (the “Act,” formerly known as the “Tax Cuts and Jobs Act”) was signed into law and provides for significant changes to the U.S. Internal Revenue Code of 1986, as amended (the “Code”). The Act has widespread applicability to companies, including impacting corporate tax rates, business-related exclusions, deduction and credits, and international taxability. Among other items important to the Company, the Act implements a territorial tax system, imposes a one-time transition tax on deemed repatriated earnings of foreign subsidiaries, and permanently reduces the federal corporate tax rate to 21% effective January 1, 2018. As the Company’s fiscal year end falls on September 30, the statutory federal corporate tax rate for fiscal 2018 will be prorated to 24.5%, with the statutory rate for fiscal 2019 and beyond at 21%.
The effective tax rates related to continuing operations for the six months ended March 31, 2018 and April 1, 2017 were (15.0)% and 35.7%, respectively. The effective tax rate used for interim reporting purposes is based on management’s best estimate of factors impacting the effective tax rate for the full fiscal year and includes the impact of discrete items recognized in the quarter. There can be no assurance that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year end.
At September 30, 2017, the Company had a net deferred tax liability of $157.5 million. Under GAAP, the Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company’s net deferred tax liability of $157.5 million was determined based on the current enacted federal tax rate of 35% prior to the passage of the Act. As a result of the reduction in the corporate income tax rate from 35% to 21% under the Act, the Company estimates the value of its net deferred tax liability has been reduced by $45.9 million, which has been recorded in the “Income tax expense (benefit) from continuing operations” line in the Condensed Consolidated Statement of Operations for the three and six months ended March 31, 2018. The Company’s actual write-down may vary from the current estimate due to a number of uncertainties and factors, including the completion of the Company’s consolidated financial statements as of and for the year ending September 30, 2018, and further clarifications of the Act which cannot be anticipated at this time. In accordance with SAB 118, any necessary measurement adjustments will be recorded and disclosed within one year from the enactment date within the period the adjustments are determined.
The Act also provides for a one-time transition tax on “deemed repatriation” of accumulated foreign earnings for the year ended September 30, 2018. The Company estimates U.S. federal tax on the deemed repatriation of $14.0 million. However, after the application of $10.7 million of foreign tax credits generated from the repatriation, plus utilization of $3.2 million of foreign tax credit carryovers previously reserved under a full valuation allowance, no cash payment is expected to be due. Additionally, state tax expense is expected to increase by $0.1 million as a result of the deemed repatriation in the current fiscal year. These amounts have been recorded in the “Income tax expense (benefit) from continuing operations” line in the Condensed Consolidated Statement of Operations for the three and six months ended March 31, 2018. While the Company believes this is a reasonable estimate of the effects of the transition tax, it is subject to further analysis which cannot be completed until after the end of the fiscal year. The additional information and analysis may cause the actual liability to differ from the current estimate. In accordance with SAB 118, any necessary measurement adjustments will be recorded and disclosed within one year from the enactment date within the period the adjustments are determined. During the three months ended March 31, 2018, the Company repatriated cash from a foreign subsidiary resulting in the liquidation of substantially all of the assets of the subsidiary and the write-off of

25
Table of Contents

accumulated foreign currency translation loss adjustments of $11.7 million within the “Other non-operating expense, net” line in the Condensed Consolidated Statements of Operations.
The Company does not currently have the information necessary to determine a reasonable estimate of the current or deferred impacts of certain aspects of the Act including those related to executive compensation and international taxation that are not effective until the Company's fiscal year ended September 30, 2019. These include the potential impacts of the limitation on tax deductions for performance-based compensation of certain individuals and the so-called “Global Intangible Low-Tax Income (GILTI)” and “Foreign Derived Intangible Income (FDII)” per the Act. Because of the complexity of the new GILTI tax rules, the Company continues to evaluate this provision of the Act and the application of ASC 740. Under GAAP, the Company is permitted to make an accounting policy election of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company’s selection of an accounting policy with respect to the new GILTI tax rules will depend, in part, on analyzing its global income to determine whether it expects to have future U.S. inclusions in taxable income related to GILTI and, if so, what the impact is expected to be. Because whether the Company expects to have future U.S. inclusions in taxable income related to GILTI depends on not only its current structure and estimated future results of global operations but also its intent and ability to modify its structure and/or its business, the Company is not yet able to reasonably estimate the effect of this provision of the Act. Therefore, in accordance with SAB 118, the Company has not made any adjustments related to potential GILTI tax in its financial statements and has not made a policy election decision regarding whether to record deferred taxes on GILTI. Similarly, in accordance with SAB 118, the Company has not adjusted its current or deferred taxes for the tax effects of FDII or the limitation on tax deductions for performance-based compensation in the current period. Estimates of these amounts will be recorded in the first reporting period in which a reasonable estimate can be determined.
Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. Subject to the following exceptions, the Company is no longer subject to examination by these tax authorities for fiscal years prior to 2014. The Company is currently under examination by certain U.S. state and local tax authorities. The tax periods under examination are limited to fiscal years 2011 through 2016. During the second quarter of fiscal 2018, an IRS audit covering fiscal years 2011 through 2013 was effectively settled with no material impact to the consolidated financial statements. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.
The Company currently anticipates that few of its open and active audits will be resolved within the next twelve months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although audit outcomes and the timing of audit payments are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.
NOTE 12. CONTINGENCIES
Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows.
Regulatory Matters
At March 31, 2018, $4.2 million was accrued in the “Other liabilities” line in the Condensed Consolidated Balance Sheets for environmental actions, the majority of which are for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.

26
Table of Contents

Other
The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.
In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, the Company, along with its Chief Executive Officer, have been named as defendants in four actions filed on and after June 27, 2012, which have been consolidated, and, on March 31, 2017, certified as a class action in the United States District Court for the Southern District of California as In re Morning Song Bird Food Litigation, Lead Case No. 3:12-cv-01592-JAH-AGS. The plaintiffs allege various statutory and common law claims associated with the Company’s sale of wild bird food products and a plea agreement entered into in previously pending government proceedings associated with such sales. The plaintiffs allege, among other things, a class action on behalf of all persons and entities in the United States who purchased certain bird food products. The plaintiffs assert: (i) hundreds of millions of dollars in monetary damages (actual, compensatory, consequential, and restitution); (ii) punitive and treble damages; (iii) injunctive and declaratory relief; (iv) pre-judgment and post-judgment interest; and (v) costs and attorneys’ fees. The Company and its Chief Executive Officer dispute the plaintiffs’ assertions and intend to vigorously defend the consolidated action. No accruals have been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time. There can be no assurance that future developments with respect to this action, whether as a result of an adverse outcome or as a result of significant defense costs, will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows.
The Company has been named as a defendant in In re Scotts EZ Seed Litigation, Case No. 12-cv-4727 (VB), a New York and California class action lawsuit filed August 9, 2012 in the United States District Court for the Southern District of New York that asserts claims under false advertising and other legal theories based on a marketing statement on the Company’s EZ Seed grass seed product from 2009 to 2012. The plaintiffs seek, on behalf of themselves and purported class members, various forms of monetary and non-monetary relief, including statutory damages that they contend could amount to hundreds of millions of dollars. The Company has defended the action vigorously, and disputes the plaintiffs’ claims and theories, including the recoverability of statutory damages. In 2017, the Court eliminated certain claims, narrowed the case in certain respects, and permitted the case to continue proceeding as a class action. On August 7, 2017, the Court requested briefs on the Company’s request for interlocutory review of issues relating to the recoverability of statutory damages in a class action by the United States Court of Appeals for the Second Circuit and, on August 31, 2017, approved that request. On January 8, 2018, however, the Second Circuit denied the interlocutory appeal request. The parties engaged in mediation on April 9, 2018 and agreed in principle to a preliminary settlement of the outstanding claims on April 10, 2018. The preliminary settlement would require the Company to pay certain attorneys’ and administrative fees and provide certain payments to the class members. The preliminary settlement will not be finalized until after the court approves the settlement and a claims process determines the payments to be provided to the class members. During the three months ended March 31, 2018, the Company recognized a charge of $10.2 million for a probable loss related to this matter within the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. The resolution of the claims process may result in additional losses in excess of the amount accrued, however, the Company does not believe a reasonably possible loss in excess of the amount accrued would be material to, nor have a material adverse effect on, the Company’s financial condition, results of operations or cash flows.
The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.

27
Table of Contents

NOTE 13. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.
Exchange Rate Risk Management
The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans with foreign subsidiaries that are denominated in local currencies. At March 31, 2018, the notional amount of outstanding currency forward contracts was $252.9 million, with a negative fair value of $0.7 million. At April 1, 2017, the notional amount of outstanding currency forward contracts was $288.4 million, with a negative fair value of $3.5 million. At September 30, 2017, the notional amount of outstanding currency forward contracts was $268.3 million, with a fair value of $1.8 million. The fair value of currency forward contracts is determined using forward rates in commonly quoted intervals for the full term of the contracts. The outstanding contracts will mature over the next fiscal quarter.
Interest Rate Risk Management
The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. Since the interest rate swap agreements have been designated as hedging instruments, unrealized gains or losses resulting from adjusting these swaps to fair value are recorded as elements of accumulated other comprehensive income (loss) (“AOCI”) within the Condensed Consolidated Balance Sheets. The fair value of the swap agreements is determined based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date.
The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a maximum total U.S. dollar equivalent notional amount of $1,300.0 million at March 31, 2018, $1,150.0 million at April 1, 2017 and $1,100.0 million at September 30, 2017. Refer to “NOTE 8. DEBT” for the terms of the swap agreements outstanding at March 31, 2018. Included in the AOCI balance at March 31, 2018 was a gain of $0.9 million related to interest rate swap agreements that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.
Commodity Price Risk Management
The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea requirements. The contracts are designated as hedges of the Company’s exposure to future cash flow fluctuations associated with the cost of urea. The objective of the hedges is to mitigate the earnings and cash flow volatility attributable to the risk of changing prices. Since the contracts have been designated as hedging instruments, unrealized gains or losses resulting from adjusting these contracts to fair value are recorded as elements of AOCI within the Condensed Consolidated Balance Sheets. Realized gains or losses remain as a component of AOCI until the related inventory is sold. Upon sale of the underlying inventory, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at March 31, 2018 was a loss of $0.3 million related to urea derivatives that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.
The Company also uses derivatives to partially mitigate the effect of fluctuating diesel costs on operating results. These financial instruments are carried at fair value within the Condensed Consolidated Balance Sheets. Changes in the fair value of derivative contracts that qualify for hedge accounting are recorded in AOCI. The effective portion of the change in fair value remains as a component of AOCI until the related fuel is consumed, at which time the accumulated gain or loss on the derivative contract is reclassified to cost of sales. Changes in the fair value of derivatives that do not qualify for hedge accounting are recorded as an element of cost of sales. At March 31, 2018, there were no amounts included within AOCI.
The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:
COMMODITY
 
MARCH 31,
2018
 
APRIL 1,
2017
 
SEPTEMBER 30,
2017
Urea
 
42,000 tons
 
28,500 tons
 
76,500 tons
Diesel
 
3,360,000 gallons
 
5,544,000 gallons
 
5,586,000 gallons
Heating Oil
 
1,092,000 gallons
 
1,680,000 gallons
 
1,386,000 gallons

28
Table of Contents

Fair Values of Derivative Instruments
The fair values of the Company’s derivative instruments were as follows:
 
 
 
 
ASSETS / (LIABILITIES)
DERIVATIVES DESIGNATED AS  HEDGING INSTRUMENTS
 
 
 
MARCH 31,
2018
 
APRIL 1,
2017
 
SEPTEMBER 30,
2017
 
BALANCE SHEET LOCATION
 
FAIR VALUE
 
 
 
 
(In millions)
Interest rate swap agreements
 
Prepaid and other current assets
 
$
1.5

 
$
0.7

 
$
1.3

 
 
Other assets
 
1.9

 
0.8

 
—

 
 
Other current liabilities
 
—

 
(1.9
)
 
(0.8
)
 
 
Other liabilities
 
—

 
(0.7
)
 
(0.4
)
Commodity hedging instruments
 
Prepaid and other current assets
 
—

 
—

 
3.2

 
 
Other current liabilities
 
(0.5
)
 
(0.2
)
 
—

Total derivatives designated as hedging instruments
 
$
2.9

 
$
(1.3
)
 
$
3.3

 
 
 
 
 
 
 
 
 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
 
BALANCE SHEET LOCATION
 
 
 
 
 
 
Currency forward contracts
 
Prepaid and other current assets
 
$
0.3

 
$
0.5

 
$
2.0

 
 
Other current liabilities
 
(1.0
)
 
(4.0
)
 
(0.2
)
Commodity hedging instruments
 
Prepaid and other current assets
 
1.1

 
—

 
0.6

 
 
Other current liabilities
 
—

 
(0.1
)
 
—

Total derivatives not designated as hedging instruments
 
0.4

 
(3.6
)
 
2.4

Total derivatives
 
$
3.3

 
$
(4.9
)
 
$
5.7


The effect of derivative instruments on AOCI and the Condensed Consolidated Statements of Operations was as follows: 
DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS
 
AMOUNT OF GAIN / (LOSS) RECOGNIZED IN AOCI
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
 
 
(In millions)
Interest rate swap agreements
 
$
2.1

 
$
0.4

 
$
2.5

 
$
2.5

Commodity hedging instruments
 
(0.1
)
 
(0.4
)
 
0.3

 
0.5

Total
 
$
2.0

 
$
—

 
$
2.8

 
$
3.0


DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS
 
RECLASSIFIED FROM AOCI INTO
STATEMENT OF OPERATIONS
 
AMOUNT OF GAIN / (LOSS)
THREE MONTHS ENDED
 
SIX MONTHS ENDED
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
 
 
 
 
(In millions)
Interest rate swap agreements
 
Interest expense
 
$
0.1

 
$
(0.9
)
 
$
0.2

 
$
(1.2
)
Commodity hedging instruments
 
Cost of sales
 
1.0

 
(0.2
)
 
1.0

 
(0.3
)
Total
 
$
1.1

 
$
(1.1
)
 
$
1.2

 
$
(1.5
)


29
Table of Contents

DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
 
RECOGNIZED IN
STATEMENT OF OPERATIONS
 
AMOUNT OF GAIN / (LOSS)
THREE MONTHS ENDED
 
SIX MONTHS ENDED
MARCH 31,
2018
 
APRIL 1,
2017
 
MARCH 31,
2018
 
APRIL 1,
2017
 
 
 
 
(In millions)
Currency forward contracts
 
Other income / expense, net
 
$
(2.6
)
 
$
(2.2
)
 
$
(5.2
)
 
$
7.0

Commodity hedging instruments
 
Cost of sales
 
0.2

 
(0.9
)
 
1.5

 
—

Total
 
$
(2.4
)
 
$
(3.1
)
 
$
(3.7
)
 
$
7.0

NOTE 14. FAIR VALUE MEASUREMENTS
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
The following describes the valuation methodologies used for financial assets and liabilities measured at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.
Derivatives
Derivatives consist of currency, interest rate and commodity derivative instruments. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Commodity contracts are measured using observable commodity exchange prices in active markets.
These derivative instruments are classified within Level 2 of the valuation hierarchy and are included within other assets and other liabilities in the Company’s Condensed Consolidated Balance Sheets, except for derivative instruments expected to be settled within the next 12 months, which are included within prepaid and other current assets and other current liabilities.
Cash Equivalents
Cash equivalents consist of highly liquid financial instruments with original maturities of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.
Other
Other consists of investment securities in non-qualified retirement plan assets and the Company’s option to increase its economic interest in Bonnie Plants, Inc. (the “Bonnie Option”). Investment securities in non-qualified retirement plan assets are valued using observable market prices in active markets and are classified within Level 1 of the valuation hierarchy. The fair value of the Bonnie Option is determined using a simulation approach, whereby the total value of the loan receivable and optional exchange for additional equity was estimated considering a distribution of possible future cash flows discounted to present value using an appropriate discount rate, and is classified in Level 3 of the fair value hierarchy.
Long-Term Debt
In connection with the acquisition of a controlling interest in Gavita during fiscal 2016, the Company recorded a loan to the noncontrolling ownership group of Gavita. On October 2, 2017, the Company’s Hawthorne segment acquired the remaining 25% noncontrolling interest in Gavita, which included extinguishment of the loan to the noncontrolling ownership group of Gavita with a fair value and carrying value of $55.6 million. The fair value of the loan was $37.2 million and $55.6 million at April 1, 2017

30
Table of Contents

and